Chr5 gain, being more frequent in C3-AITL than in C1-AITL, might also contribute to poor survival in C3 due to increased signaling of IL-4/IL-13, which is located on 5q31, via a direct gene dosage effect of aneuploidy [46]. The gene discussed is IL13; the disease is angioimmunoblastic T-cell lymphoma.